Flu vaccine makers may face a last-minute scramble to produce enough doses after an FDA advisory committee meeting was ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class ...

Glancy Prongay & Murray LLP reminds investors of the upcoming April 14, 2025 deadline to file a lead plaintiff motion in the class action filed on ...

COLORADO SPRINGS—Sierra Space has announced pharmaceutical giant Merck as its first commercial rideshare partner for the ...

This adjustment represents a significant 119.54% increase in share count, a 1.06% impact on the current portfolio, with a total value of $425.87 million. The second largest increase was TE ...

NewAmsterdam Pharma's obicetrapib lowers LDL-C in Phase 3 trials, showing promise as a CETP inhibitor. Read more on NAMS ...

Authorities allege that the brothers shipped the counterfeit and adulterated drugs from India, accepting payments via wire ...

After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.

Merck (MRK) ended the recent trading session at $92.25, demonstrating a +1.84% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily gain of 1.59%.

The Open Source Week initiative launched by Chinese AI startup DeepSeek concluded on Friday with the release of its fifth ...

The pharmaceutical industry helped build factory farming. Now it’s muddying the debate over meat’s carbon footprint.